Newcastle Magnetic Resonance Centre, Institute of Cellular Medicine, Campus for Ageing and Vitality, Newcastle University, Newcastle, UK.
Int J Geriatr Psychiatry. 2013 Jun;28(6):567-72. doi: 10.1002/gps.3860. Epub 2012 Jul 22.
Visuo-perceptual abnormalities are a prominent feature in dementia with Lewy bodies (DLB) and also occur in Alzheimer's disease (AD) to a lesser extent. We studied the progression of visuo-perceptual abnormalities over a 12-month period in DLB and AD by using a novel computerised test battery.
Following our previous work using the Newcastle Visual Perception (NEVIP) battery, we re-assessed 16 AD, 12 DLB and 28 similar-aged comparison participants 12 months after initial baseline assessment.
DLB visual perception at follow-up showed worse performance than AD (U = 43, p = 0.027); however, there were no significant changes in visuo-perceptual scores between baseline assessment and 12-month assessment within groups. A poor baseline score on the NEVIP predicted subsequent deterioration on the Bristol Activities of Daily Living Scale (rs = -0.725, p = 0.014) in DLB participants but not in the AD group.
The NEVIP is a reliable test of visuo-perception, relatively independent of cognitive decline, with predictive value in identifying DLB participants at risk of functional decline. Visuo-perceptual dysfunction is a core feature of the disorder for some DLB patients and was stable over the 12-month period examined here.
视知觉异常是路易体痴呆(DLB)的一个突出特征,在阿尔茨海默病(AD)中也有较轻程度的发生。我们通过使用一种新型计算机测试电池,研究了 12 个月内 DLB 和 AD 中视知觉异常的进展情况。
在使用纽卡斯尔视觉感知(NEVIP)电池进行了先前的工作之后,我们在最初的基线评估后 12 个月重新评估了 16 名 AD、12 名 DLB 和 28 名年龄相近的对照组参与者。
与 AD 相比,DLB 在随访时的视觉感知表现更差(U=43,p=0.027);然而,各组在基线评估和 12 个月评估之间,视知觉评分均无显著变化。NEVIP 的基线评分较差预示着 DLB 参与者随后在布里斯托尔日常生活活动量表(Bristol Activities of Daily Living Scale)上的恶化(rs=-0.725,p=0.014),但在 AD 组中则无此情况。
NEVIP 是一种可靠的视知觉测试,与认知衰退相对独立,对识别有功能下降风险的 DLB 参与者具有预测价值。对于某些 DLB 患者来说,视知觉功能障碍是该疾病的核心特征,在我们这里检查的 12 个月期间保持稳定。